TULSA Abstracts at the 15th Interventional MRI Symposium Strengthen Real-World Evidence, Clinical Differentiation, and Platform Expansion Opportunity
TORONTO, Oct. 14, 2026 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) today announced that five abstracts presented at the 15th Interventional MRI (“iMRI”) Symposium in Boston, Massachusetts, reinforce the growing body of evidence supporting the real-world performance, clinical differentiation, and platform expansion potential of the TULSA…
Read original article on Financial Post →Related news
-
'It's so strange, it's perfect': Angine de Poitrine's album illustrator on why we need their art right now
-
Who else besides Danielle Smith is saying 'yes to the nine' in Alberta's referendum?
-
Trial set to begin for former Calgary bar owner accused of sexually assaulting 5 women
-
Fact-checking the B.C. NDP's environmental record
- Datavault AI Appoints Shareholder and Investment Executive Jeffrey Tirman to the Board of Directors
- Pan Global Expands Near-Surface High-Grade Gold Discovery at Cármenes Project, Spain: Drillholes Return 7.29g/t Au Over 9 Meters and 1.53g/t Au Over 38 Meters
-
Watch the B.C. election provincial leaders’ debate live
- PharmaCorp Announces CFO Transition and Appointment of Andrew Hodson as Chief Financial Officer